Abstract
Objective of this study was to evaluate the efficacy and adverse drug reactions (ADR) of palipeddone sustained release tablet in the treatment of schizophrenia in outpatients. Outpatients with schizophrenia treated with palipeddone sustained release tablet (observation group) in our hospital from Apr. to Sep. in 2009 were followed up and compared with those treated with risperidone (control group) during the same period. PANSS and TESS were applied to evaluate efficacy and ADR. Results suggest that the cure rates were 42.4% for control group and 49.6% for observation group. The effective rates were 74.8% for control group and 80.3% for observation group (P
| Original language | English |
|---|---|
| Pages (from-to) | 146-150 |
| Number of pages | 5 |
| Journal | Activitas Nervosa Superior |
| Volume | 55 |
| Issue number | 4 |
| State | Published - 2013 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Psychiatry and Mental health
- Clinical Neurology
- Behavioral Neuroscience
- Biological Psychiatry
- Cognitive Neuroscience
- Neurology
Cite this
Clinical observation on palipeddone sustained release tablet in the treatment of schizophrenia. / Xiong, Dian Zhang; Yuan, Yu Ru; Gao, Rong; Wang, Qing; Chang, Wen Pin.
In: Activitas Nervosa Superior, Vol. 55, No. 4, 2013, p. 146-150.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Clinical observation on palipeddone sustained release tablet in the treatment of schizophrenia
AU - Xiong, Dian Zhang
AU - Yuan, Yu Ru
AU - Gao, Rong
AU - Wang, Qing
AU - Chang, Wen Pin
PY - 2013
Y1 - 2013
N2 - Objective of this study was to evaluate the efficacy and adverse drug reactions (ADR) of palipeddone sustained release tablet in the treatment of schizophrenia in outpatients. Outpatients with schizophrenia treated with palipeddone sustained release tablet (observation group) in our hospital from Apr. to Sep. in 2009 were followed up and compared with those treated with risperidone (control group) during the same period. PANSS and TESS were applied to evaluate efficacy and ADR. Results suggest that the cure rates were 42.4% for control group and 49.6% for observation group. The effective rates were 74.8% for control group and 80.3% for observation group (P
AB - Objective of this study was to evaluate the efficacy and adverse drug reactions (ADR) of palipeddone sustained release tablet in the treatment of schizophrenia in outpatients. Outpatients with schizophrenia treated with palipeddone sustained release tablet (observation group) in our hospital from Apr. to Sep. in 2009 were followed up and compared with those treated with risperidone (control group) during the same period. PANSS and TESS were applied to evaluate efficacy and ADR. Results suggest that the cure rates were 42.4% for control group and 49.6% for observation group. The effective rates were 74.8% for control group and 80.3% for observation group (P
UR - http://www.scopus.com/inward/record.url?scp=84893483606&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84893483606&partnerID=8YFLogxK
M3 - Article
VL - 55
SP - 146
EP - 150
JO - Activitas Nervosa Superior
JF - Activitas Nervosa Superior
SN - 1802-9698
IS - 4
ER -